Effects of chromium extract on cytokine release by mononuclear cells

Biomaterials

Volumn 19, Issue 1-3, 1998, Pages 283-291

  Granchi, Donatella ^a   Verri, Elisabetta ^a   Ciapetti, Gabriela ^a   Savarino, Lucia ^a   Cenni, Elisabetta ^a   Gori, Alessandra ^a   Pizzoferrato, Arturo ^a  

^a Lab for Biocompatibiity Res on I   (Italy)

Author keywords

Blood mononuclear cells; Bone remodelling; Chromium; Cytokines; Prosthesis loosening

Indexed keywords

BIOCOMPATIBILITY; BIOSYNTHESIS; BLOOD; BONE; CELL CULTURE; CHEMICAL ACTIVATION; CHROMIUM; COMPOSITION EFFECTS; DNA; GROWTH KINETICS;

BLOOD MONONUCLEAR CELLS; BONE REMODELLING; CYTOKINES; PROSTHESIS LOOSENING;

IMPLANTS (SURGICAL);

CHROMIUM; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONONUCLEAR CELL; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING;

BONE RESORPTION; CELL SURVIVAL; CHROMIUM; CYTOKINES; DNA; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PHYTOHEMAGGLUTININS; RECEPTORS, INTERLEUKIN-2; STIMULATION, CHEMICAL;

EID: 0031864499     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(97)00148-8     Document Type: Article

References (28)

1. [1] Black J, Maitin EC. Serum concentration of chromium cobalt and nickel after total hip replacement: a six month study. Biomaterials 1983;4:160-64.
2. [2] Merritt K, Brown SA. Hypersensitivity to metallic biomaterials. In: Williams DF, editor. Systemic aspects of biocompatibility, vol. 2. Boca Raton, Florida: CRC Press, 1981:33-48.
3. [3] Dobbs HS, Minski MJ. Metal ion release after total joint replacement. Biomaterials 1980;1:193-98.
4. [4] Woodman JL, Black J, Nunamaker DM. Release of cobalt and nickel from a new total finger joint prosthesis made of vitallium. J Biomed Mater Res 1983;17:655-68.
5. [5] Brown SA, Farnsworth LJ, Merritt K, Crowe TD. In vitro and in vivo metal ion release. J Biomed Mater Res 1988;22:321-38.
6. [6] Khan AJ, Partridge NC. Bone resorption in vivo. In: Bone, vol. 2: the osteoclast, Boca Raton, FL: CRC Press, 1991:119-40.
7. [7] Wallach S, Avioli LV, Feinblatt JD. Cytokines and bone metabolism. Calcif Tissue Int 1993;53:293-96.
8. [8] Chiba J, Rubash HE, Kim KJ, Iwaki Y. The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop 1994;300:304-12.
9. [9] Jiranek WA, Machado M, Jasty M et al. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am 1993;75:863-79.
10. [10] Haynes DR, Roger SD, Hay S, Pearcy MJ, Howie DW. The differences in toxicity and release of bone-resorbing mediators induced by titanium and cobalt-chromium alloy wear particles. J Bone Joint Surg 1993;75-A:825-34.
11. [11] Granchi D, Ciapetti G, Savarino L, Cavédagna D, Donati ME, Pizzoferrato A. Assessment of metal extract toxicity on human lymphocytes cultured in vitro. J Biomed Mater Res 1996;31:183-91.
12. [12] ISO/Draft International Standard 10993, Biological Testing of Medical Devices, Part 12: Sample Preparation and Reference Materials, 1994.
13. [13] Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 1968;97:1-4.
14. [14] Rao J, Otto WR. Fluorimetric DNA assay for cell growth estimation. Analyt Biochem 1992;207:186-92.
15. [15] Rae N. Metal enzyme interactions. In: Williams DF, editor. Systemic aspects of biocompatibility, vol. 1. Boca Raton, Florida: CRC Press, 1981:21-38.
16. [16] Yang J, Merritt K. Detection of antibodies against corrosion products in patients after Co-Cr total joint replacements. J Biomed Mater Res 1994;28:1249-58.
17. [17] Gruber HE. Bone and the immune system. Proc Soc Exp Biol Med 1991;197:219-25.
18. [18] Kuroki T, Shingu M, Koshihara Y, Nobunaga M. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification, and calcium release by human osteoblastic cells. Br J Rheumatol 1994;33:224-30.
19. [19] Centrella M, McCarthy TL, Canalis E. Growth factors and cytokines. In: Bone, vol. 4, Bone Metabolism and mineralization, Boca Raton, FL: CRC Press, 1992:47-72.
20. [20] Mann GN, Jacobs TW, Buchinsky FJ et al. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. Endocrinology 1994;135: 1077-83.
21. [21] Causey AL, Wooten RM, Clem LW, Bly JE. A serum free medium for human primary T lymphocyte culture. J Immunol Meth 1994;175:115-21.
22. [22] Kelso A, Metcalf D, Gough NM. Independent regulation of granulocyte-macrophage colony-stimulting factor and multi-lineage colony-stimulating factor production in T lymphocyte clones. J Immunol 1986;136:1718-25.
23. [23] Nelson DL, Rubin LA, Kurman CC, Fritz ME, Boutin B. An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro. J Clin Immunol 1986;6:114-20.
24. [24] De Groote D, Gevaert Y, Lopez M et al. Novel method for the measurement of cytokine production by a one-stage procedure. J Immunol Meth 1993;163:259-67.
25. [25] DeFife KM, Yun JK, Azeez A et al. Adhesion and cytokine production by monocytes on poly(2-methacryloyloxyethyl phosphorylcholine-co-alkyl methacrylate)-coated polymers. J Biomed Mater Res 1995;29:431-39.
26. [26] Al Saffar N, Kwaja HA, Kadoya Y, Revell PA. Assessment of the role of GM-CSF in the cellular transformation and the development of erosive lesions around orthopedic implants. Am J Clin Pathol 1996;105:628-39.
27. [27] Yoshino T, Kondo E, Cao L et al. Inverse expression of bcl-2 protein and fas antigen in lymphoblasts in peripheral lymph nodes and activates peripheral blood T and B lymphocytes. Blood 1994;7:1856-61.
28. [28] Wang JY, Tsukayama DT, Wicklund BH, Gustilo RB. Inhibition of T and B cell proliferation by titanium, cobalt, and chromium: role of IL-2 and IL-6. J Biomed Mater Res 1996;32:655-61.